A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma

International Journal of Hematology

Volumn 74, Issue 3, 2001, Pages 303-308

  Takahashi, Naoto ^a   Miura, Ikuo ^a   Chubachi, Akihiko ^b   Miura, Akira B ^a   Nakamura, Shigeo ^c  

^a AKITA UNIVERSITY   (Japan)

^b Department of Internal Medicine   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

CD56; Cytotoxic molecules; Epstein Barr virus; Lymphoma associated hemophagocytic syndrome; Nasal and nasal type NK T cell lymphoma

Indexed keywords

CD56 ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLASSIFICATION; EPSTEIN BARR VIRUS; FEMALE; GENETICS; HISTIOCYTOSIS; HUMAN; IMMUNOPHENOTYPING; MALE; MORTALITY; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; T CELL LYMPHOMA; VIROLOGY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD56; FEMALE; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMAN; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGE; NOSE NEOPLASMS; RETROSPECTIVE STUDIES; RNA, VIRAL; SURVIVAL RATE;

EID: 0035492091     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982065     Document Type: Article

References (21)

1. Ng CS, Chan JK, Cheng PN, Szeto SC. Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer. 1986;58:67-71.
2. Chan JK, Ng CS. Malignant lymphoma, natural killer cells and hemophagocytic syndrome. Pathology. 1989;21:154-155.
3. Chan EY, Pi D, Chan GT, Todd D, Ho FC. Peripheral T-cell lymphoma presenting as hemophagocytic syndrome. Hematol Oncol. 1989;7:275-285.
4. Okuda T, Sakamoto S, Deguchi T, et al. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol. 1991:38:321-323.
5. Chubachi A, Imai H, Nishimura S, Saitoh M, Miura AB. Nasal T-cell lymphoma associated with hemophagocytic syndrome. Immuno-histochemical and genotypic studies. Arch Pathol Lab Med. 1992:116:1209-1212.
6. Wong KF, Chan JK, Ng CS, Chu YC, Li LP, Chan CH. Large cell lymphoma with initial presentation in the bone marrow. Hematol Oncol. 1992;10:261-271.
7. Kawabata Y, Chubachi A, Miura I, Saitoh M, Watanuki T, Miura AB. Hemophagocytic syndrome in a patient with immunoblastic lymphadenopathy-like T-cell lymphoma [in Japanese, abstract in English]. Jpn J Clin Hematol 1994;35:75-79.
8. Chubachi A, Miura AB. Lymphoma-associated hemophagocytic syndrome in adults: a review of the literature [in Japanese]. Jpn J Clin Hematol. 1994:35:837-845.
9. Jaffe ES, Costa J, Fauci AS, Cossman J,Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med. 1983;75:741-749.
10. Falini B, Pileri S, De Solas I, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood. 1990;75:434-444.
11. Yao M, Cheng AL, Su IJ, et al. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Br J Haematol. 1994;87:535-543.
12. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Palhol 1999;111:S8-S12.
13. Kagami Y, Suzuki R,Taji H, et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol. 1999:23:1184-1200.
14. Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer. 1993;72:909-916.
15. Su IJ.Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in Epstein-Barr virus-associated T-Iymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymph. 1995;19:401-406.
16. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood. 1992;79:2432-2437.
17. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89: 4501-4513.
18. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood. 1996;87:1474-1483.
19. The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. New Engl J Med. 1993;329:987-994
20. Liang R,Todd D,Chan TK,et al.Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 1995;13: 666-670.
21. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype,and treatment outcome in 113 patients.J Clin Oncol. 1998:16:70-77.